• 1. Distinction of trans–cis photoisomers with comparable optical properties in multiple-state photochromic systems – examining a molecule with three azobenzenes via in situ irradiation NMR spectroscopy?
  Jonas Kind,Lukas Kaltschnee,Martin Leyendecker,Christina M. Thiele Chem. Commun., 2016,52, 12506-12509
• 2. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502
• 3. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 4. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 5. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines Pyrrolidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolidines

Introduction to 2-[(2S)-pyrrolidin-2-yl]acetic acid hydrochloride (CAS No. 53912-85-9)

2-[(2S)-pyrrolidin-2-yl]acetic acid hydrochloride, identified by the Chemical Abstracts Service Number (CAS No.) 53912-85-9, is a significant compound in the realm of pharmaceutical chemistry and biochemistry. This compound belongs to the class of chiral amino acids derivatives, characterized by its unique stereochemical configuration at the pyrrolidine ring. The hydrochloride salt form enhances its solubility and stability, making it a valuable intermediate in synthetic chemistry and drug development.

The stereochemistry of (2S)-pyrrolidin-2-yl group is crucial for its biological activity, as enantiomeric purity directly influences pharmacokinetic and pharmacodynamic properties. This aspect has garnered considerable attention in recent years, particularly in the design of enantiomerically pure drugs to minimize side effects and maximize therapeutic efficacy. The synthesis of such chiral compounds often requires advanced catalytic methods and stereoselective reactions, which are areas of active research in organic chemistry.

Recent advancements in computational chemistry have enabled more precise predictions of molecular interactions, aiding in the rational design of molecules like 2-[(2S)-pyrrolidin-2-yl]acetic acid hydrochloride. High-throughput screening and molecular docking studies have been instrumental in identifying potential drug candidates that incorporate this scaffold. For instance, studies have shown that derivatives of this compound exhibit promising activity against various enzymatic targets, including proteases and kinases, which are pivotal in numerous disease pathways.

In the context of medicinal chemistry, the utility of 2-[(2S)-pyrrolidin-2-yl]acetic acid hydrochloride extends to its role as a building block for more complex molecules. Its pyrrolidine core is a common motif in bioactive scaffolds, found in several FDA-approved drugs due to its ability to interact with biological targets through hydrogen bonding and hydrophobic interactions. The introduction of the carboxylic acid moiety at the second position further expands its synthetic versatility, allowing for derivatization into esters, amides, or other functional groups essential for drug optimization.

Current research focuses on leveraging this compound's structural features to develop novel therapeutics. For example, modifications to the side chain or introduction of additional substituents have been explored to enhance binding affinity or metabolic stability. The hydrochloride salt form not only improves solubility but also ensures consistent drug delivery profiles, which are critical for clinical applications. This has led to investigations into its potential use in formulations designed for oral or parenteral administration.

The biological significance of (2S)-pyrrolidin-2-yl derivatives has been further underscored by their involvement in various physiological processes. The pyrrolidine ring mimics natural amino acids, enabling it to participate in protein-protein interactions and enzyme inhibition. Recent studies have highlighted its role in modulating neurotransmitter systems, making it a candidate for therapeutic intervention in neurological disorders. Additionally, its structural similarity to certain endogenous metabolites suggests it may interact with cellular pathways involved in inflammation and oxidative stress.

Synthetic methodologies for producing 53912-85-9 have seen significant improvements over the years. Transition-metal-catalyzed reactions, such as asymmetric hydrogenation and cross-coupling reactions, have enabled more efficient and scalable synthesis routes. These advancements not only reduce production costs but also allow for greater control over stereochemical outcomes. The development of greener synthetic protocols aligns with broader sustainability goals in pharmaceutical manufacturing, ensuring that processes are environmentally friendly while maintaining high yields and purity standards.

The pharmacological profile of hydrochloride salt forms is another area of interest. By stabilizing the compound's active conformation and improving bioavailability, these salts enhance drug performance. Comparative studies have demonstrated that formulations containing this salt exhibit superior pharmacokinetic profiles compared to free base forms. This has implications for dosing regimens and patient compliance, as well as for reducing variability in therapeutic responses.

In conclusion, 53912-85-9 stands out as a versatile and biologically relevant compound with significant potential in drug discovery and development. Its unique stereochemical features, combined with its synthetic accessibility, make it an attractive scaffold for designing novel therapeutics targeting various diseases. As research continues to uncover new applications and refine synthetic strategies, 53912-85-9 is poised to remain a cornerstone in pharmaceutical chemistry.

• 137693-28-8((2S)-1-methyl-2-Pyrrolidineacetic acid)
• 19615-30-6(2-Piperidylacetic Acid Hydrochloride)
• 439918-59-9((R)-2-Pyrrolidineacetic acid Hydrochloride)
• 71985-79-0(2-(pyrrolidin-2-yl)acetic acid hydrochloride)
• 56879-46-0(2-(Pyrrolidin-2-yl)acetic acid)
• 5626-43-7(2-(1-Methylpyrrolidin-2-yl)acetic acid)
• 56633-75-1(2-[(2S)-pyrrolidin-2-yl]acetic acid)
• 10024-28-9(Butanoic acid,3-(dodecylamino)-)
• 103435-27-4(Butanoic acid, 3-(octylamino)-)
• 61350-65-0(2-[(2R)-pyrrolidin-2-yl]acetic acid)